| Autor: |
Silva Vania Benido, Fonseca Liliana, Duarte Diana Borges, Puga Francisca Marques, Assuncao Guilherme, Garrido Susana, Teixeira Sofia, Vilaverde Joana, Cardoso Maria Helena |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Endocrine Regulations, Vol 57, Iss 1, Pp 144-151 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
1336-0329 |
| DOI: |
10.2478/enr-2023-0018 |
| Popis: |
Objective. Adjuvant therapy with sodium-glucose cotransport 2 inhibitors (SGLT2i) in type 1 diabetes (T1D) is associated with an improvement in glycemic control, but increases the risk of diabetic ketoacidosis (DKA). However, real-life studies in individuals with T1D under continuous subcutaneous insulin infusion (CSII) are still scarce. We present the first real-life study performed in patients with T1D exclusively treated with CSII. The aim of the present study was to assess the metabolic impact and safety of SGLT2i in T1D individuals under CSII. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
